LONDON, April 24, 2014 /PRNewswire/ --
The trading session on Wednesday, April 23, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,501.65, down 0.08% and the NASDAQ Composite closed at 4,126.97, down 0.83%. The S&P 500 finished the session 0.22% lower at 1,875.39. During the session, Telecommunication Services, Information Technology, and Health Care sectors exerted a drag, while some positive momentum was observed in the Energy, Industrials, and Financials sectors. The S&P 500 Health Care Sector Index edged 0.48% lower to finish the day at 670.12, while it has gained 1.59% in the last three months. Investor-Edge has initiated coverage on the following equities: Boston Scientific Corp. (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Medtronic Inc. (NYSE: MDT) and Insulet Corp. (NASDAQ: PODD). Free technical research on BSX, ABT, MDT and PODD can be downloaded upon signing up at:
http://www.investor-edge.com/1623-register
Boston Scientific Corp.'s stock edged 0.44% lower on Wednesday, ending the day at $13.69. The stock recorded a trading volume of 9.00 million shares, which was below its three months average volume of 12.02 million shares. The stock oscillated between $13.62 and $13.82 during the trading session. The company's stock traded at a PE ratio of 30.70. Boston Scientific Corp.'s shares have gained 0.29% in the previous three trading sessions, 6.79% in the last one month and 13.89% since the start of this year. The stock is trading above its 50-day and 200-day moving averages of $13.24 and $12.07, respectively. Further, the shares of the company have a Relative Strength Index (RSI) of 57.68. Sign up today to read free research on BSX at:
http://www.investor-edge.com/1623-BSX-24Apr2014.pdf
Shares in Abbott Laboratories fluctuated between $38.52 and $38.82 before closing the trading session flat at previous day's closing price of $38.60. On Wednesday, shares in Abbott Laboratories reported a trading volume of 3.56 million shares, which was below its three months average volume of 8.85 million shares. Shares of the company traded at a PE ratio of 21.89. The company's shares have advanced 0.55% in the last one month and 0.70% on YTD basis, but they have edged lower by 0.85% in the previous three trading sessions. The company's stock is trading below its 50-day moving average. Abbott Laboratories's 50-day moving average of $38.77 is above its 200-day moving average of $36.95. Moreover, shares of the company have an RSI of 52.80. Sign up today to read free research on ABT at:
http://www.investor-edge.com/1623-ABT-24Apr2014.pdf
On Wednesday, Medtronic Inc.'s stock recorded a trading volume of 3.52 million shares, which was below its three months average volume of 5.07 million shares. The stock ended the day 0.14% higher at $58.38, and registered an intraday range of $57.95 and $58.50. Medtronic Inc.'s shares have edged lower by 0.29% in the previous three trading sessions and 0.76% in the last one month, while they have advanced 1.73% on YTD basis. The company's stock is trading below its 50-day moving average. Medtronic Inc.'s 50-day moving average of $59.02 is above its 200-day moving average of $56.60. Furthermore, the stock traded at a PE ratio of 15.83 and has an RSI of 41.24. Sign up today to read free research on MDT at:
http://www.investor-edge.com/1623-MDT-24Apr2014.pdf
Shares in Insulet Corp. declined 2.17% on Wednesday, closing the day at $41.91. A total of 0.43 million shares were traded, which was below its three months average volume of 0.64 million shares. The stock moved between $41.59 and $43.24 during the session. The company's stock has lost 3.70% over the previous three trading sessions and 15.91% in the last one month, while it has gained 12.96% since the beginning of this year. The company shares are trading above their 200-day moving average. Insulet Corp.'s 50-day moving average of $46.25 is above its 200-day moving average of $38.71. Additionally, the company's stock has an RSI of 40.57. Sign up today to read free research on PODD at:
http://www.investor-edge.com/1623-PODD-24Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.investor-edge.com/
SOURCE Investor-Edge
